TAPTAN PLUS
TELMISARTAN AND HYDROCHIOROTHIAZIDE · by ACE LIFE SCIENCES
Composition
Tab 20/12.5 mg: Telmisartan 20 mg, hydrochlorothiazide 12.5 mg.Tab40/12.5 mg: Telmisartan 40 mg, hydrochlorothiazide 12.5 mg. Tab80/12.5 mg:Telmisartan 80 mg, hydrochlorothiazide 12.5 mg.
Indications & Dosage
Hypertension not adequately controlled by telmisartan alone: Adults: 1 tab daily using the strength as clinically appropriate. Children: Not recommended.
Contraindications
Cholestasis, biliary obstruction, severe hepatic or severe renal impairment, refractory hypokalaemia; hypercalcaemia.
Precautions
Mild to moderate renal or hepatic impairment, progressive liver disease, renovascular hypertension, kidney transplant, intravascular vol-ume depletion, severe congestive heart failure, renal artery stenosis, primary aldosteronism, aortic or mitral stenosis, obstructive cardiomyopathy, diabetes. Monitor serum electrolyte, creatinine and uric acid levels during therapy.
Interactions
Lithium, digoxin, diuretics, corticosteroids, ACE inhibitors, K+-sparing diuretics or K+ supplements, cyclosporin, tacrolimus, hypoglycaemic agents, anionic exchange resins, NSAIDS, pressor amines, allopurinol, probenecid, sulfnpyrazone, calcium supplements, diazoxide, beta-blockers, anticholinergics, amantadine, methotrexate, cyclophosphamide, baclofen, alcohol barbiturates, antidepressants.
Pregnancy
Contraindicated in pregnancy.
Lactation
Not recommended.
Side Effects
Arthralgia, back pain, chest pain, eczema, GI disturbances, influenza-like symptoms, leg cramps, myalgia, pharyngitis, sinusitis, urinary-tract infection, asthenia, syncope, abnormal vision, anxiety, dry mouth, flatulence, sweating, tendinitis-like symptoms, vertigo. Rare: Blood disorders, bradycardia, depression, dyspnea, eosinophilia, increase in uric acid, insomnia, pruritus, rash, tachycardia